Magic mushroom compound tested for OCD in small trial
Symptom relief
Not yet recruiting
This early-stage trial will test whether psilocybin, the active ingredient in magic mushrooms, can safely reduce symptoms of obsessive-compulsive disorder (OCD). Twenty adults with moderate-to-severe OCD who haven't responded to standard treatments will receive either a low (10mg…
Phase: PHASE1, PHASE2 • Sponsor: Francisco A Moreno • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC